Development Of Novel Remyelination Promoting Therapeutics For Multiple Sclerosis And Other Neurological Disorders

Project Details

StatusFinished
Effective start/end date28/03/1930/11/22

Funding

  • Pheno Therapeutics Ltd: £637,555.57
  • Pheno Therapeutics Ltd: £1,182,182.59